Eo2 Société Anonyme (EPA:ALEO2)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Market Capitalization	6	8	12	14	12	14
Market Cap Growth	-34.35%	-34.35%	-13.98%	21.08%	-18.05%	67.22%
Enterprise Value	14	15	11	18	16	18
Last Close Price	2.38	3.72	4.80	5.60	4.60	5.62
PE Ratio	-	-	17.12	3.09	18.73	51.40
Forward PE	-	7.64	7.64	7.64	7.64	7.64
PS Ratio	0.19	0.27	0.36	0.35	0.38	0.57
PB Ratio	0.27	0.38	0.55	0.63	0.62	0.77
P/TBV Ratio	0.31	0.43	0.65	0.74	0.74	0.93
P/FCF Ratio	-	-	-	3.43	3.60	32.36
P/OCF Ratio	3.05	4.30	-	2.56	2.24	12.37
EV/Sales Ratio	0.45	0.49	0.33	0.46	0.54	0.74
EV/EBITDA Ratio	11.61	12.32	4.17	2.10	5.79	7.26
EV/EBIT Ratio	-	-	28.07	2.99	22.20	54.86
EV/FCF Ratio	-14.90	-	-	4.44	5.09	41.90
Debt / Equity Ratio	0.54	0.54	0.59	0.53	0.67	0.77
Debt / EBITDA Ratio	9.30	9.30	4.73	1.38	4.41	5.61
Debt / FCF Ratio	-	-	-	2.91	3.88	32.36
Asset Turnover	0.72	0.72	0.75	0.94	0.80	0.64
Inventory Turnover	3.23	3.23	4.66	7.75	6.49	4.71
Quick Ratio	1.23	1.23	1.76	2.05	2.89	2.96
Current Ratio	1.80	1.80	2.63	2.51	3.37	3.88
Return on Equity (ROE)	-3.15%	-3.15%	2.36%	21.50%	2.23%	0.69%
Return on Assets (ROA)	-2.24%	-2.24%	0.55%	8.98%	1.21%	0.54%
Return on Capital (ROIC)	-2.81%	-2.81%	0.73%	11.59%	1.45%	0.64%
Return on Capital Employed (ROCE)	-	-	1.10%	17.40%	2.30%	1.00%
Earnings Yield	-1.64%	-1.17%	5.84%	32.33%	5.34%	1.95%
FCF Yield	-16.20%	-11.49%	-55.75%	29.16%	27.75%	3.09%
Buyback Yield / Dilution	8.54%	8.54%	2.50%	3.77%	-7.16%	8.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.